Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory C Shearer

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Atherosclerosis|May 2, 2015
Effects of niacin and omega-3 fatty acids on the apolipoproteins in overweight patients with elevated triglycerides and reduced HDL cholesterolOlga V Savinova, Kristi Fillaus, William S Harris, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|July 22, 2011
Plasma fatty acids in chronic kidney disease: nervonic acid predicts mortalityGregory C Shearer, Juan J Carrero, Olof Heimbürger, et al.
Plos One|May 8, 2009
Red blood cell fatty acid patterns and acute coronary syndromeGregory C Shearer, James V Pottala, John A Spertus, et al.
Journal of the American Society of Nephrology : JASN|March 25, 2005
Graded effects of proteinuria on HDL structure in nephrotic ratsGregory C Shearer, John W Newman, Bruce D Hammock, et al.
Journal of Lipid Research|May 15, 2007
Proteinuria increases oxylipid concentrations in VLDL and HDL but not LDL particles in the ratJohn W Newman, George A Kaysen, Bruce D Hammock, et al.
Journal of Lipid Research|August 13, 2009
Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl estersGregory C Shearer, William S Harris, Theresa L Pedersen, et al.
Journal of Molecular and Cellular Cardiology|December 18, 2016
ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4Timothy D O'Connell, Robert C Block, Shue P Huang, et al.
Plos One|August 14, 2014
Reduced apolipoprotein glycosylation in patients with the metabolic syndromeOlga V Savinova, Kristi Fillaus, Linhong Jing, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 16, 2012
Cis-vaccenic acid and the Framingham risk score predict chronic kidney disease: the multi-ethnic study of atherosclerosis (MESA)Robert Block, Lisa Kakinami, Scott Liebman, et al.
Journal of Lipid Research|August 16, 2012
Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trialGregory C Shearer, James V Pottala, Susan N Hansen, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Atherosclerosis|May 2, 2015
Effects of niacin and omega-3 fatty acids on the apolipoproteins in overweight patients with elevated triglycerides and reduced HDL cholesterolOlga V Savinova, Kristi Fillaus, William S Harris, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|July 22, 2011
Plasma fatty acids in chronic kidney disease: nervonic acid predicts mortalityGregory C Shearer, Juan J Carrero, Olof Heimbürger, et al.
Plos One|May 8, 2009
Red blood cell fatty acid patterns and acute coronary syndromeGregory C Shearer, James V Pottala, John A Spertus, et al.
Journal of the American Society of Nephrology : JASN|March 25, 2005
Graded effects of proteinuria on HDL structure in nephrotic ratsGregory C Shearer, John W Newman, Bruce D Hammock, et al.
Journal of Lipid Research|May 15, 2007
Proteinuria increases oxylipid concentrations in VLDL and HDL but not LDL particles in the ratJohn W Newman, George A Kaysen, Bruce D Hammock, et al.
Journal of Lipid Research|August 13, 2009
Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl estersGregory C Shearer, William S Harris, Theresa L Pedersen, et al.
Journal of Molecular and Cellular Cardiology|December 18, 2016
ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4Timothy D O'Connell, Robert C Block, Shue P Huang, et al.
Plos One|August 14, 2014
Reduced apolipoprotein glycosylation in patients with the metabolic syndromeOlga V Savinova, Kristi Fillaus, Linhong Jing, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 16, 2012
Cis-vaccenic acid and the Framingham risk score predict chronic kidney disease: the multi-ethnic study of atherosclerosis (MESA)Robert Block, Lisa Kakinami, Scott Liebman, et al.
Journal of Lipid Research|August 16, 2012
Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trialGregory C Shearer, James V Pottala, Susan N Hansen, et al.
Pageof 7